Publications

2018

In vitro characterization of the eFlow closed system nebulizer with glycopyrrolate inhalation solution.

Pham, S., Ferguson, G. T., Kerwin, E., Goodin, T., Wheeler, A., & Bauer, A. (2018).
Journal of aerosol medicine and pulmonary drug delivery, 31(3), 162-169.

To Publication


Monitoring nebuliser usage & lung function in clinical trials.

Fuchs, C., & Koehler, Y. (2018).
ONdrugDelivery Publishing 2018, June 6th, 87, 66-70.

To Publication


2017

Monitoring adherence to treatment regimen of inhaled medication use in a clinical trial with an investigational eFlow nebulizer (eTrack).

Fuchs, C., Brosig, M., Finke, M., Fiebig, D., Soni, P., Tutuncu, A., Saponjic, R., & Knoch, M. (2017).
European Respiratory Journal 2017, 50.

To Publication


2015

Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients.

Sawicki, G. S., Chou, W., Raimundo, K., Trzaskoma, B., & Konstan, M. W. (2015).
Journal of Cystic Fibrosis, 14(6), 777-783.

To Publication


In-vitro Study of Aerosolised Colistin Delivered to the Nasal Tract via a Pulsating Aerosol Delivery Device (Vibrent®).

Schuschnig, U., Seidler, A., Seemann, S., & Knoch, M. (2015).
20th International Congress of the International Society for Aerosols in Medicine (ISAM), Munich, Germany, May 30 to June 3, 2015.

To Publication


2014

Drug delivery to paranasal sinuses using pulsating aerosols.

Moeller, W., Schuschnig, U., Bartenstein, P., Meyer, G., Haeussinger, K., Schmid, O., & Becker, S. (2014).
Journal of aerosol medicine and pulmonary drug delivery, 27(4), 255-263.

To Publication


The eFlow ‘‘closed system’’(CS) - a novel device platform for liquid aerosol drug-device combinations.

Gallem, T. (2014).
ONdrugDelivery Publishing 2014, June 19th, 50,13-16 (ondrugdelivery.com).

To Publication


A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBI.

Griese, M., Eismann, C., Börner, G., Denk, O., Schierholz, J. M., Keller, M., Mazurek, H., & Kappler, M. (2014).
Journal of aerosol medicine and pulmonary drug delivery, 27(3), 185-192.

To Publication


Some cystic fibrosis patients do not tolerate tobramycin dry powder inhalation.

Boerner, G., Prante, S., & Borella, F. (2014).
Journal of Cystic Fibrosis, 13, S121.

To Publication


2013

Topical Drug Delivery in Chronic Rhinosinusitis Patients before and after Sinus Surgery Using Pulsating Aerosols.

Möller, W., Schuschnig, U., Celik, G., Münzing, W., Bartenstein, P., Häussinger, K., Kreyling, W. G., Knoch, M., Canis, M., & Becker, S. (2013).
PloS one, 8(9), e74991.

To Publication


Pulsating Aerosols - New Therapy Options for Upper Airway Diseases.

Möller, W., Schuschnig, U., Becker, S., Saba, G. K., Münzing, W., Bartenstein, P., & Knoch, M. (2013).
Journal of aerosol medicine and pulmonary drug delivery, 26(4), 257-258.


2012

Assessing Modeled C O 2 Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants.

Mundt, C., Sventitskiy, A., Cehelsky, J. E., Patters, A. B., Tservistas, M., Hahn, M. C., Juhl, G., & DeVincenzo, J. P. (2012).
ISRN pediatrics, 2012.

To Publication


2011

A Comparison of Amount and Speed of Deposition Between the PARI LC STAR® Jet Nebulizer and an Investigational eFlow® Nebulizer.

Coates, A. L., Green, M., Leung, K., Chan, J., Ribeiro, N., Ratjen, F., & Charron, M. (2011).
Journal of aerosol medicine and pulmonary drug delivery, 24(3), 157-163.

To Publication


Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.

Moller, W., Saba, G. K., Haussinger, K., Becker, S., Keller, M., & Schuschnig, U. (2011).
Rhinology, 2011.

To Publication


Objective Evaluation Of Adherence To Inhaled Liposomal Cyclosporin Therapy For Lung Transplant Patients In A Clinical Trial.

Fuchs, C., Prante, S., Pokorski, R., Lim, H., Denk, O., Seemann, S., & Knoch, M. (2011).
Pediatric Pulmonology, 46(34), 418.

To Publication


2010

Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.

Möller, W., Schuschnig, U., Khadem Saba, G., Meyer, G., Junge-Hülsing, B., Keller, M., & Häussinger, K. (2010).
Otolaryngology - Head and Neck Surgery, 142(3), 382-388.

To Publication


Optimising drug and device together for novel aerosol therapies.

Keller, M., & Knoch, M. (2010).
ONdrugDelivery Magazine, (17), 12-16.

To Publication


2009

Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation.

Behr, J., Zimmermann, G., Baumgartner, R., Leuchte, H., Neurohr, C., Brand, P., Herpich, C., Sommerer, K., Seitz, K., Menges, G., Tillmanns, S., Keller, M., & the Munich Lung Transplant Group (2009).
Journal of aerosol medicine and pulmonary drug delivery, 22(2), 121-130.

To Publication


A Novel Nebuliser for the Simultaneous Administration of siRNA and Supplemental Oxygen for RSV in Infants.

Tservistas, M., Hahn, M., DeVincenzo, J., Hetzer, U., Uhlig, M., Cehelsky, J., Walsh, E., Kreutzer, T., O`Connor, S., Knoch, M. (2009).
Drug Delivery to the Lungs - DDL20, Edinburgh, United Kingdom, December 9-11, 2009. Proceedings: 53-56.

To Publication


2006

New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.

Lass, J. S., Sant, A., & Knoch M. (2006).
Expert opinion on drug delivery, 3(5), 693-702.

To Publication


2005

The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.

Knoch, M., & Keller M. (2005).
Expert opinion on drug delivery, 2(2), 377-390.

To Publication

Contact us

Do you have any questions about our technology, partnering approach and services?

Please contact us!
eFlow-partneringpari.com